Byoung Chul Cho

Researcher Next ID · RN-005675

Researcher · Medicine

Seoul, South Korea

Not currently recruitingFunding unknown

Research interests

Medicine

Lung Cancer Treatments and Mutations

Cancer Immunotherapy and Biomarkers

Lung Cancer Research Studies

Colorectal Cancer Treatments and Studies

Lung Cancer Diagnosis and Treatment

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(18)32409-7
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(18)32409-7
Overall Survival with Osimertinib in Untreated, EGFR -Mutated Advanced NSCLC
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1913662
Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1713137
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1709937

No projects listed.